Progress in the development of genetic immunization

References

• Cohen SN, Chang AC, Boyer HW, Helling B. Construction of biologically functional bacterial plasmids in vitro. Proc. Natl Acad. Sci. USA70(11), 3240–3244 (1973).
   PubMed Web of Science ®Google Scholar
• Crea R, Kraszewski A, Hirose T, Itakura K. Chemical synthesis of genes for human insulin. Proc. Natl Acad. Sci. USA75(12), 5765–5769 (1978).
   PubMed Web of Science ®Google Scholar
• Jonczyk A, Keefer LM, Naithani VK, Gattner HG, De Meyts P, Zahn H. Preparation and biological properties of human insulin. Hoppe Seylers Z. Physiol. Chem.362(5), 557–561 (1981).
   PubMedGoogle Scholar
• Keefer LM, Piron MA, De Meyts P. Human insulin prepared by recombinant DNA techniques and native human insulin interact identically with insulin receptors. Proc. Natl Acad. Sci. USA78(3), 1391–1395 (1981).
   PubMedGoogle Scholar
• Smith KA, Nelson PN, Warren P, Astley SJ, Murray PG, Greenman J. Demystified…recombinant antibodies. J. Clin. Pathol.57(9), 912–917 (2004).
   PubMed Web of Science ®Google Scholar
• Gill P, Jeffreys AJ, Werrett DJ. Forensic application of DNA ‘fingerprints’. Nature318(6046), 577–579 (1985).
   PubMed Web of Science ®Google Scholar
• Panicali D, Paoletti E. Construction of poxviruses as cloning vectors: insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus. Proc. Natl Acad. Sci. USA79(16), 4927–4931 (1982).
   PubMed Web of Science ®Google Scholar
• Panicali D, Davis SW, Weinberg RL, Paoletti E. Construction of live vaccines by using genetically engineered poxviruses: biological activity of recombinant vaccinia virus expressing influenza virus hemagglutinin. Proc. Natl Acad. Sci. USA80(17), 5364–5368 (1983).
   PubMed Web of Science ®Google Scholar
• McAleer WJ, Buynak EB, Maigetter RZ, Wampler DE, Miller WJ, Hilleman MR. Human hepatitis B vaccine from recombinant yeast. Nature307(5947), 178–180 (1984).
   PubMed Web of Science ®Google Scholar
• McAleer WJ, Markus HZ, Wampler DE et al. Vaccine against human hepatitis B virus prepared from antigen derived from human hepatoma cells in culture. Proc. Soc. Exp. Biol. Med.175(3), 314–319 (1984).
   PubMedGoogle Scholar
• McKee AS, Munks MW, Marrack P. How do adjuvants work? Important considerations for new generation adjuvants. Immunity27(5), 687–690 (2007).
   PubMed Web of Science ®Google Scholar
• Grandi G. Antibacterial vaccine design using genomics and proteomics. Trends Biotechnol.19(5), 181–188 (2001).
   PubMed Web of Science ®Google Scholar
• Ward JI, Cherry JD, Chang S-J et al. Efficacy of an acellular pertussis vaccine among adolescents and adults. N. Engl. J. Med.353(15), 1555–1563 (2005).
   PubMed Web of Science ®Google Scholar
• Steere AC, Sikand VK, Meurice F et al. Vaccination against lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein a with adjuvant. N. Engl. J. Med.339(4), 209–215 (1998).
   PubMed Web of Science ®Google Scholar
• Tang DC, DeVit M, Johnston SA. Genetic immunization is a simple method for eliciting an immune response. Nature356(6365), 152–154 (1992).
   PubMed Web of Science ®Google Scholar
• Lu S, Wang S, Grimes-Serrano JM. Current progress of DNA vaccine studies in humans. Expert Rev. Vaccines7(2), 175–191 (2008).
   PubMed Web of Science ®Google Scholar
• Horner AA, Datta SK, Takabayashi K et al. Immunostimulatory DNA-based vaccines elicit multifaceted immune responses against HIV at systemic and mucosal sites. J. Immunol.167(3), 1584–1591 (2001).
   PubMed Web of Science ®Google Scholar
• Barfoed AM, Blixenkrone-Moller M, Jensen MH, Botner A, Kamstrup S. DNA vaccination of pigs with open reading frame 1–7 of PRRS virus. Vaccine22(27–28), 3628–3641 (2004).
   PubMedGoogle Scholar
• Donnelly J, Berry K, Ulmer JB. Technical and regulatory hurdles for DNA vaccines. Int. J. Parasitol.33(5–6), 457 (2003).
   PubMed Web of Science ®Google Scholar
• Babiuk LA, Babiuk SL, Loehr BI, van Drunnen Littel-van den H. Nucleic acid vaccines: research tool or commercial reality. Vet. Immunol. Immunopathol.76(1–2), 1–23 (2000).
   PubMedGoogle Scholar
• Barry MA, Lai WC, Johnston SA. Protection against mycoplasma infection using expression-library immunization. Nature377(6550), 632–635 (1995).
   PubMed Web of Science ®Google Scholar
• Forde GM. Rapid-response vaccines: does DNA offer a solution? Nat. Biotech.23(9), 1059 (2005).
   PubMed Web of Science ®Google Scholar
• Jones WE. What’s news. J. Equine Vet. Sci.24(1), 9–13 (2004).
   Google Scholar
• Corbeil S, Kurath G, Lapatra SE. Fish DNA vaccine against infectious hematopoietic necrosis virus: efficacy of various routes of immunisation. Fish Shellfish Immunol.10(8), 711–723 (2000).
   PubMed Web of Science ®Google Scholar
• Powell K. DNA vaccines – back in the saddle again? Nat. Biotechnol.22(7), 799–801 (2004).
   PubMed Web of Science ®Google Scholar
• Donnelly JJ, Ulmer JB, Liu MA. DNA vaccines. Dev. Biol. Stand.95, 43–53 (1998).
   PubMedGoogle Scholar
• Fernandez-Borges N, Brun A, Whitton JL et al. DNA vaccination can break immunological tolerance to prp in wild-type mice and attenuates prion disease after intracerebral challenge. J. Virol.80(20), 9970–9976 (2006).
   PubMed Web of Science ®Google Scholar
• Manickan E, Yu Z, Rouse BT. DNA immunization of neonates induces immunity despite the presence of maternal antibody. J. Clin. Invest.100(9), 2371–2375 (1997).
   PubMed Web of Science ®Google Scholar
• Hassett DE, Zhang J, Slifka M, Whitton JL. Immune responses following neonatal DNA vaccination are long-lived, abundant, and qualitatively similar to those induced by conventional immunization. J. Virol.74(6), 2620–2627 (2000).
   PubMedGoogle Scholar
• Li BW, Rush A, Zhang SR, Curtis KC, Weil GJ. Antibody responses to Brugia malayi antigens induced by DNA vaccination. Filaria J.3(1), 1 (2004).
   PubMedGoogle Scholar
• Grifantini R, Finco O, Bartolini E et al. Multi-plasmid DNA vaccination avoids antigenic competition and enhances immunogenicity of a poorly immunogenic plasmid. Eur. J. Immunol.28(4), 1225–1232 (1998).
   PubMed Web of Science ®Google Scholar
• Wizemann TM, Heinrichs JH, Adamou JE et al. Use of a whole genome approach to identify vaccine molecules affording protection against Streptococcus pneumoniae infection. Infect. Immun.69(3), 1593–1598 (2001).
   PubMed Web of Science ®Google Scholar
• Piedrafita D, Xu DM, Hunter D, Harrison RA, Liew FY. Protective immune responses induced by vaccination with an expression genomic library of Leishmania major. J. Immunol.163(3), 1467–1472 (1999).
   PubMed Web of Science ®Google Scholar
• Manoutcharian K, Terrazas LI, Gevorkian G, Govezensky T. Protection against murine cysticercosis using cDNA expression library immunization. Immunol. Lett.62(3), 131–136 (1998).
   PubMed Web of Science ®Google Scholar
• Brayton KA, Vogel SW, Allsopp BA. Expression library immunization to identify protective antigens from Cowdria ruminantium. Ann. NY Acad. Sci.849, 369–371 (1998).
   PubMedGoogle Scholar
• Alberti E, Acosta A, Sarmiento ME et al. Specific cellular and humoral immune response in BALB/c mice immunised with an expression genomic library of Trypanosoma cruzi. Vaccine16(6), 608–612 (1998).
   PubMed Web of Science ®Google Scholar
• Stemke-Hale K, Kaltenboeck B, DeGraves FJ et al. Screening the whole genome of a pathogen in vivo for individual protective antigens. Vaccine23(23), 3016–3025 (2005).
   PubMedGoogle Scholar
• Mwau M, Cebere I, Sutton J et al. A human immunodeficiency virus 1 (HIV-1) clade A vaccine in clinical trials: stimulation of HIV-specific T-cell responses by DNA and recombinant modified vaccinia virus Ankara (MVA) vaccines in humans. J. Gen. Virol.85(Pt 4), 911–919 (2004).
   PubMed Web of Science ®Google Scholar
• MacGregor RR, Boyer JD, Ugen KE et al. First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response. J. Infect. Dis.178(1), 92–100 (1998).
   PubMed Web of Science ®Google Scholar
• Wang R, Doolan DL, Le TP et al. Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine. Science282(5388), 476–480 (1998).
   PubMed Web of Science ®Google Scholar
• Borgne SL, Michel ML, Camugli S, Corre B, Le Grand R, Riviere Y. Expansion of HBV-specific memory CTL primed by dual HIV/HBV genetic immunization during SHIV primary infection in rhesus macaques. Vaccine19(17–19), 2485–2495 (2001).
   PubMedGoogle Scholar
• Locher CP, Sykes KF, Blackbourn DJ, Johnston SA. Immune responses in baboons vaccinated with HIV-2 genetic expression libraries. J. Med. Primatol.31(6), 323–329 (2002).
   PubMed Web of Science ®Google Scholar
• Sullivan NJ, Sanchez A, Rollin PE, Yang ZY, Nabel GJ. Development of a preventive vaccine for Ebola virus infection in primates. Nature408(6812), 605–609 (2000).
   PubMed Web of Science ®Google Scholar
• Ugen KE, Nyland SB, Boyer JD et al. DNA vaccination with HIV-1 expressing constructs elicits immune responses in humans. Vaccine16(19), 1818–1821 (1998).
   PubMed Web of Science ®Google Scholar
• Calarota S, Bratt G, Nordlund S et al. Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients. Lancet351(9112), 1320–1325 (1998).
   PubMed Web of Science ®Google Scholar
• Kumar S, Villinger F, Oakley M et al. A DNA vaccine encoding the 42 kDa C-terminus of merozoite surface protein 1 of Plasmodium falciparum induces antibody, interferon-γ and cytotoxic T cell responses in rhesus monkeys: immuno-stimulatory effects of granulocyte macrophage-colony stimulating factor. Immunol. Lett.81(1), 13–24 (2002).
   PubMed Web of Science ®Google Scholar
• Bhardwaj D, Hora B, Singh N et al. Immunogenicity and protective efficacy of three DNA vaccines encoding pre-erythrocytic- and erythrocytic-stage antigens of Plasmodium cynomolgi in rhesus monkeys. FEMS Immunol. Med. Microbiol.34(1), 33–43 (2002).
   PubMedGoogle Scholar
• Satkauskas S, Bureau MF, Mahfoudi A, Mir LM. Slow accumulation of plasmid in muscle cells: supporting evidence for a mechanism of DNA uptake by receptor-mediated endocytosis. Mol. Ther.4(4), 317–323 (2001).
   PubMed Web of Science ®Google Scholar
• Cox GJ, Zamb TJ, Babiuk LA. Bovine herpesvirus 1: immune responses in mice and cattle injected with plasmid DNA. J. Virol.67(9), 5664–5667 (1993).
   PubMed Web of Science ®Google Scholar
• Armaleo D, Ye GN, Klein TM, Shark KB, Sanford JC, Johnston SA. Biolistic nuclear transformation of Saccharomyces cerevisiae and other fungi. Curr. Genet.17(2), 97–103 (1990).
   PubMed Web of Science ®Google Scholar
• Tree JA, Bembridge G, Hou S et al. An assessment of different DNA delivery systems for protection against respiratory syncytial virus infection in the murine model: gene gun delivery induces IgG in the lung. Vaccine22(19), 2438–2443 (2004).
   PubMed Web of Science ®Google Scholar
• Haynes JR. Particle-mediated DNA vaccine delivery to the skin. Expert Opin. Biol. Ther.4(6), 889–900 (2004).
   PubMed Web of Science ®Google Scholar
• Hayes SC, World MJ. Adverse reactions to anthrax immunisation in a military field hospital. J. R. Army Med. Corps.146(3), 191–195 (2000).
   PubMedGoogle Scholar
• Hooper JW, Custer DM, Thompson E, Schmaljohn CS. DNA vaccination with the Hantaan virus M gene protects hamsters against three of four HFRS hantaviruses and elicits a high-titer neutralizing antibody response in rhesus monkeys. J. Virol.75(18), 8469–8477 (2001).
   PubMed Web of Science ®Google Scholar
• Fuller DH, Corb MM, Barnett S, Steimer K, Haynes JR. Enhancement of immunodeficiency virus-specific immune responses in DNA-immunized rhesus macaques. Vaccine15(8), 924 (1997).
   PubMed Web of Science ®Google Scholar
• Horton H, Vogel TU, Carter DK et al. Immunization of rhesus macaques with a DNA prime/modified vaccinia virus Ankara boost regimen induces broad simian immunodeficiency virus (SIV)-specific T-cell responses and reduces initial viral replication but does not prevent disease progression following challenge with pathogenic SIVmac239. J. Virol.76(14), 7187–7202 (2002).
   PubMed Web of Science ®Google Scholar
• Fuller DH, Simpson L, Cole KS et al. Gene gun-based nucleic acid immunization alone or in combination with recombinant vaccinia vectors suppresses virus burden in rhesus macaques challenged with a heterologous SIV. Immunol. Cell. Biol.75(4), 389–396 (1997).
   PubMed Web of Science ®Google Scholar
• Drape RJ, Macklin MD, Barr LJ, Jones S, Haynes JR, Dean HJ. Epidermal DNA vaccine for influenza is immunogenic in humans. Vaccine24(21), 4475–4481 (2006).
   PubMed Web of Science ®Google Scholar
• Chen D, Zuleger C, Chu Q, Maa Y-F, Osorio J, Payne LG. Epidermal power immunizations with a recombinant HIV gp120 targets Lagerhans cells and induces enhanced immune responses. AIDS Res. Hum. Retroviruses18(10), 715–722 (2002).
   PubMed Web of Science ®Google Scholar
• Fynan EF, Webster RG, Fuller DH, Haynes JR, Santoro JC, Robinson HL. DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc. Natl Acad. Sci. USA90(24), 11478–11482 (1993).
   PubMed Web of Science ®Google Scholar
• Bennett AM, Phillpotts RJ, Perkins SD, Jacobs SC, Williamson ED. Gene gun mediated vaccination is superior to manual delivery for immunisation with DNA vaccines expressing protective antigens from Yersinia pestis or Venezuelan equine encephalitis virus. Vaccine18(7–8), 588–596 (1999).
   PubMedGoogle Scholar
• Glenn GM, Kenney RT, Ellingsworth LR, Frech SA, Hammond SA, Zoeteweij JP. Transcutaneous immunization and immunostimulant strategies: capitalizing on the immunocompetence of the skin. Expert Rev. Vaccines2(2), 253–267 (2003).
   PubMed Web of Science ®Google Scholar
• Somiari S, Glasspool-Malone J, Drabick JJ et al. Theory and in vivo application of electroporative gene delivery. Mol. Ther.2(3), 178–187 (2000).
   PubMed Web of Science ®Google Scholar
• Donnelly JJ, Ulmer JB, Shiver JW, Liu MA. DNA vaccines. Annu. Rev. Immunol.15, 617–648 (1997).
   PubMed Web of Science ®Google Scholar
• Gronevik E, Mathiesen I, Lomo T. Early events of electroporation-mediated intramuscular DNA vaccination potentiate Th1-directed immune responses. J. Gene. Med.7(9), 1246–1254 (2005).
   PubMed Web of Science ®Google Scholar
• Widera G, Austin M, Rabussay D et al. Increased DNA vaccine delivery and immunogenicity by electroporation in vivo. J. Immunol.164(9), 4635–4640 (2000).
   PubMed Web of Science ®Google Scholar
• Luckay A, Sidhu MK, Kjeken R et al. Effect of plasmid DNA vaccine design and in vivo electroporation on the resulting vaccine-specific immune responses in rhesus macaques. J. Virol.81(10), 5257–5269 (2007).
   PubMed Web of Science ®Google Scholar
• Porgador A, Irvine KR, Iwasaki A, Barber BH, Restifo NP, Germain RN. Predominant role for directly transfected dendritic cells in antigen presentation to CD8+ T cells after gene gun immunization. J. Exp. Med.188(6), 1075–1082 (1998).
   PubMed Web of Science ®Google Scholar
• He Y, Zhang J, Donahue C, Falo LD Jr. Skin-derived dendritic cells induce potent CD8+ T cell immunity in recombinant lentivector-mediated genetic immunization. Immunity24(5), 643–656 (2006).
   PubMed Web of Science ®Google Scholar
• Timares L, Takashima A, Johnston SA. Quantitative analysis of the immunopotency of genetically transfected dendritic cells. Proc. Natl Acad. Sci. USA95(22), 13147–13152 (1998).
   PubMed Web of Science ®Google Scholar
• Klinman DM, Sechler JM, Conover J, Gu M, Rosenberg AS. Contribution of cells at the site of DNA vaccination to the generation of antigen-specific immunity and memory. J. Immunol.160(5), 2388–2392 (1998).
   PubMed Web of Science ®Google Scholar
• Nchinda G, Kuroiwa J, Oks M et al. The efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cells. J. Clin. Invest.118(4), 1427–1436 (2008).
   PubMed Web of Science ®Google Scholar
• Barry MA, Johnston SA. Biological features of genetic immunization. Vaccine15(8), 788–791. (1997).
   PubMed Web of Science ®Google Scholar
• Ivory C, Chadee K. DNA vaccines: designing strategies against parasitic infections. Genet. Vaccines Ther.2(1), 17 (2004).
   PubMedGoogle Scholar
• Brandler P, Saikh KU, Heath D, Friedlander A, Ulrich RG. Weak anamnestic responses of inbred mice to Yersinia F1 genetic vaccine are overcome by boosting with F1 polypeptide while outbred mice remain nonresponsive. J. Immunol.161(8), 4195–4200 (1998).
   PubMedGoogle Scholar
• Bennett AM, Lescott T, Phillpotts RJ, Mackett M, Titball RW. Recombinant vaccinia viruses protect against Clostridium perfringens α-toxin. Viral Immunol.12(2), 97–105 (1999).
   PubMedGoogle Scholar
• Grosfeld H, Cohen S, Bino T et al. Effective protective immunity to Yersinia pestis infection conferred by DNA vaccine coding for derivatives of the F1 capsular antigen. Infect. Immun.71(1), 374–383 (2003).
   PubMed Web of Science ®Google Scholar
• Williamson ED, Bennett AM, Perkins SD, Beedham RJ, Miller J, Baillie LW. Co-immunisation with a plasmid DNA cocktail primes mice against anthrax and plague. Vaccine20(23–24), 2933–2941 (2002).
   PubMed Web of Science ®Google Scholar
• Garmory HS, Freeman D, Brown KA, Titball RW. Protection against plague afforded by immunisation with DNA vaccines optimised for expression of the Yersinia pestis V antigen. Vaccine22(8), 947–957 (2004).
   PubMed Web of Science ®Google Scholar
• Pashine A, Valiante NM, Ulmer JB. Targeting the innate immune response with improved vaccine adjuvants. Nat. Med.11(4 Suppl.), S63–68 (2005).
   PubMed Web of Science ®Google Scholar
• Williman J, Lockhart E, Slobbe L, Buchan G, Baird M. The use of Th1 cytokines, IL-12 and IL-23, to modulate the immune response raised to a DNA vaccine delivered by gene gun. Vaccine24(21), 4471–4474 (2006).
   PubMedGoogle Scholar
• Barouch DH, Letvin NL, Seder RA. The role of cytokine DNAs as vaccine adjuvants for optimizing cellular immune responses. Immunol. Rev.202(1), 266–274 (2004).
   PubMed Web of Science ®Google Scholar
• Khan CM, Villarreal-Ramos B, Pierce RJ et al. Construction, expression, and immunogenicity of multiple tandem copies of the Schistosoma mansoni peptide 115–131 of the P28 glutathione S-transferase expressed as C-terminal fusions to tetanus toxin fragment C in a live aro-attenuated vaccine strain of Salmonella. J. Immunol.153(12), 5634–5642 (1994).
   PubMedGoogle Scholar
• Arrington J, Braun RP, Dong L et al. Plasmid vectors encoding cholera toxin or the heat-labile enterotoxin from Escherichia coli are strong adjuvants for DNA vaccines. J. Virol.76(9), 4536–4546 (2002).
   PubMed Web of Science ®Google Scholar
• Ballard JD, Collier RJ, Starnbach MN. Anthrax toxin-mediated delivery of a cytotoxic T-cell epitope in vivo. Proc. Natl Acad. Sci. USA93(22), 12531–12534 (1996).
   PubMed Web of Science ®Google Scholar
• Carbonetti NH, Irish TJ, Chen CH et al. Intracellular delivery of a cytolytic T-lymphocyte epitope peptide by pertussis toxin to major histocompatibility complex class I without involvement of the cytosolic class I antigen processing pathway. Infect. Immun.67(2), 602–607 (1999).
   PubMed Web of Science ®Google Scholar
• Garmory HS, Brown KA, Titball RW. DNA vaccines: improving expression of antigens. Genet. Vaccines Ther.1(1), 2 (2003).
   PubMedGoogle Scholar
• Xiang Z, Ertl HC. Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines. Immunity2(2), 129–135 (1995).
   PubMed Web of Science ®Google Scholar
• Harcourt JL, Brown MP, Anderson LJ, Tripp RA. CD40 ligand (CD154) improves the durability of respiratory syncytial virus DNA vaccination in BALB/c mice. Vaccine21(21–22), 2964–2979 (2003).
   PubMed Web of Science ®Google Scholar
• Jiang C, Magee DM, Cox RA. Coadministration of interleukin 12 expression vector with antigen 2 cDNA enhances induction of protective immunity against Coccidioides immitis. Infect. Immun.67(11), 5848–5853 (1999).
   PubMedGoogle Scholar
• Sasaki S, Amara RR, Yeow WS, Pitha PM, Robinson HL. Regulation of DNA-raised immune responses by cotransfected interferon regulatory factors. J. Virol.76(13), 6652–6659 (2002).
   PubMedGoogle Scholar
• Takashima A, Morita A. Dendritic cells in genetic immunization. J. Leukoc. Biol.66(2), 350–356 (1999).
   PubMed Web of Science ®Google Scholar
• Moore KW, de Waal Malefyt R, Coffman RL, O’Garra A. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol.19, 683–765 (2001).
   PubMed Web of Science ®Google Scholar
• Barouch DH, Santra S, Schmitz JE et al. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination. Science290(5491), 486–492 (2000).
   PubMed Web of Science ®Google Scholar
• Morita A, Ariizumi K, Ritter R 3rd et al. Development of a Langerhans cell-targeted gene therapy format using a dendritic cell-specific promoter. Gene Ther.8(22), 1729–1737 (2001).
   PubMedGoogle Scholar
• Timares L, Safer KM, Qu B, Takashima A, Johnston SA. Drug-inducible, dendritic cell-based genetic immunization. J. Immunol.170(11), 5483–5490 (2003).
   PubMedGoogle Scholar
• Xiong W, Goverdhana S, Sciascia SA et al. Regulatable gutless adenovirus vectors sustain inducible transgene expression in the brain in the presence of an immune response against adenoviruses. J. Virol.80(1), 27–37 (2006).
   PubMed Web of Science ®Google Scholar
• Krueger C, Danke C, Pfleiderer K et al. A gene regulation system with four distinct expression levels. J. Gene Med.8(8), 1037–1047 (2006).
   PubMed Web of Science ®Google Scholar
• Fleischmann RD, Adams MD, White O et al. Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. Science269(5223), 496–512 (1995).
   PubMed Web of Science ®Google Scholar
• Venter JC, Adams MD, Myers EW et al. The sequence of the human genome. Science291(5507), 1304–1351 (2001).
   PubMed Web of Science ®Google Scholar
• Medini D, Serruto D, Parkhill J et al. Microbiology in the post-genomic era. Nat. Rev. Microbiol.6(6), 419–430 (2008).
   PubMed Web of Science ®Google Scholar
• Rappuoli R. Reverse vaccinology. Curr. Opin Microbiol.3(5), 445–450 (2000).
   PubMed Web of Science ®Google Scholar
• Pizza M, Scarlato V, Masignani V et al. Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing.[comment]. Science287(5459), 1816–1820 (2000).
   PubMed Web of Science ®Google Scholar
• Montigiani S, Falugi F, Scarselli M et al. Genomic approach for analysis of surface proteins in Chlamydia pneumoniae. Infecti. Immun.70(1), 368–379 (2002).
   PubMed Web of Science ®Google Scholar
• Grifantini R, Bartolini E, Muzzi A et al. Previously unrecognized vaccine candidates against group B meningococcus identified by DNA microarrays. Nat. Biotechnol.20(9), 914–921 (2002).
   PubMed Web of Science ®Google Scholar
• Sykes KF, Lewis MG, Squires B, Johnston SA. Evaluation of SIV library vaccines with genetic cytokines in a macaque challenge. Vaccine20(17–18), 2382–2395 (2002).
   PubMed Web of Science ®Google Scholar
• Stemke-Hale K, Kaltenboeck B, DeGraves FJ et al. Screening the whole genome of a pathogen in vivo for individual protective antigens. Vaccine23(23), 3016 (2005).
   PubMedGoogle Scholar
• Sykes KF, Johnston SA. Linear expression elements: a rapid, in vivo, method to screen for gene functions. Nat. Biotechnol.17(4), 355–359 (1999).
   PubMed Web of Science ®Google Scholar
• Li D, Borovkov A, Vaglenov A et al. Mouse model of respiratory Chlamydia pneumoniae infection for a genomic screen of subunit vaccine candidates. Vaccine24(15), 2917–2927 (2006).
   PubMed Web of Science ®Google Scholar
• Chambers RS, Johnston SA. High-level generation of polyclonal antibodies by genetic immunization. Nat. Biotechnol.21(9), 1088–1092 (2003).
   PubMedGoogle Scholar
• Kaufmann SHE. Novel Vaccine Strategies. Wiley-VCH, Weinheim, Germany (2004).
   Google Scholar
• Bellier B, Dalba C, Clerc B et al. DNA vaccines encoding retrovirus-based virus-like particles induce efficient immune responses without adjuvant. Vaccine24(14), 2643–2655 (2006).
   PubMedGoogle Scholar
• Svarovsky S, Borovkov A, Sykes K. Cationic gold microparticles for biolistic delivery of nucleic acids. Biotechniques (2008) (In press).
   Google Scholar